Organogenesis Holdings (ORGO) Receivables (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Receivables of $131.3 million for Q1 2026, up 16.8% year-over-year from $112.4 million in Q1 2025, and down 39.63% quarter-over-quarter from $217.5 million in Q4 2025.
Organogenesis Holdings (ORGO) Receivables (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Receivables history runs 10 years deep, the most recent figure standing at $131.3 million for Q1 2026.
- In Q1 2026, Receivables rose 16.8% year-over-year to $131.3 million; the TTM figure through Mar 2026 stood at $131.3 million (up 16.8% YoY), while the FY2025 annual figure was $246.5 million, up 106.35% from the prior year.
- Receivables for Q1 2026 stood at $131.3 million, down from $217.5 million in the prior quarter.
- The five-year high for Receivables was $217.5 million in Q4 2025, with the low at $79.5 million in Q1 2022.
- The 5-year median for Receivables is $103.6 million (2024), against an average of $114.8 million.
- The sharpest annual moves came in 2023 and 2025: Receivables declined 7.26% in 2023, then soared 97.93% in 2025.
- Organogenesis Holdings' Receivables stood at $95.8 million in 2022, then slipped by 7.26% to $88.9 million in 2023, then gained by 23.64% to $109.9 million in 2024, then jumped by 97.93% to $217.5 million in 2025, then plunged by 39.63% to $131.3 million in 2026.
- Business Quant data shows ORGO's Receivables at $131.3 million in Q1 2026, $217.5 million in Q4 2025, and $182.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 113.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 113.47 Mn |
| Mar 31, 2026 | 131.27 Mn |
| Dec 31, 2025 | 217.45 Mn |
| Sep 30, 2025 | 182.22 Mn |
| Jun 30, 2025 | 131.54 Mn |
| Mar 31, 2025 | 112.39 Mn |
| Dec 31, 2024 | 109.86 Mn |
| Sep 30, 2024 | 111.00 Mn |
| Jun 30, 2024 | 105.95 Mn |
| Mar 31, 2024 | 103.62 Mn |
| Dec 31, 2023 | 88.86 Mn |
| Sep 30, 2023 | 96.83 Mn |
| Jun 30, 2023 | 100.27 Mn |
| Mar 31, 2023 | 98.94 Mn |
| Dec 31, 2022 | 95.81 Mn |
| Sep 30, 2022 | 93.12 Mn |
| Jun 30, 2022 | 93.85 Mn |
| Mar 31, 2022 | 79.48 Mn |
| Dec 31, 2021 | 82.46 Mn |
| Sep 30, 2021 | 81.93 Mn |